<?xml version="1.0" encoding="UTF-8"?>
<p id="par0240">The potential involvement of the chemokine system during SARS-CoV-2 infection was already evident from the first COVID-19 series described by Chinese physicians in early January 2020. It was reported that several pro-inflammatory cytochines and chemokines, including CXCL10, CXCL8, CCL2, TNFα and IFNγ were higher in the plasma of COVID-19 patients as compared to healthy controls. More importantly, among infected patients, CXCL10, CCL2 and TNFα circulating concentrations (but not those of IFNγ) were found to be significantly higher in patients requiring admission to Intensive Care Units as compared to patients experiencing a less severe clinical course [
 <xref rid="bib0020" ref-type="bibr">4</xref>].
</p>
